Dietary conjugated linoleic acid decreased cachexia, macrophage tumor necrosis factor-α production, and modifies splenocyte cytokines production

Experimental Biology and Medicine

Volumn 228, Issue 1, 2003, Pages 51-58

  Yang, Mingder ^a   Cook, Mark E ^a  

^a NONE

Author keywords

Cachexia; CLA; Cytokines; Macrophage

Indexed keywords

LINOLEIC ACID; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY FAT; CACHEXIA; CELL KILLING; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DIETARY INTAKE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOD INTAKE; LYMPHOCYTE TRANSFORMATION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; SPLEEN CELL; STIMULUS RESPONSE; T LYMPHOCYTE ACTIVATION;

ANIMALIA; ZEA MAYS;

EID: 0037227098     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Pariza MW, Hargraves WA. A beef-derived mutagenesis modulator inhibits initiation of mouse epidermal tumors by 7,12-dimethylbenz[a]anthracene. Carcinogenesis 6:591-593, 1985.
2. Ip MM, Masso-Welch PA, Shoemaker SF, Shea-Eaton WK, Ip C. Conjugated linoleic acid inhibits proliferation and induces apoptosis of normal rat mammary epithelial cells in primary culture. Exp Cell Res 250:22-34, 1999.
3. Ip C, Singh M, Thompson HJ, Scimeca JA. Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat. Cancer Res 54:1212-1215, 1994.
4. Nicolosi RJ, Rogers EJ, Kritchevsky D, Scimeca JA, Huth PJ. Dietary conjugated linoleic acid reduces plasma lipoproteins and early aortic atherosclerosis in hypercholesterolemic hamsters. Artery 22:266-277, 1997.
5. Kritchevsky D. Antimutagenic and some other effects of conjugated linoleic acid. Br J Nutr 83:459-465, 2000.
6. Park Y, Albright KJ, Liu W, Storkson JM, Cook ME, Pariza MW. Effect of conjugated linoleic acid on body composition in mice. Lipids 32:853-858, 1997.
7. West DB, Delany JP, Camet PM, Blohm F, Truett AA, Scimeca J. Effects of conjugated linoleic acid on body fat and energy metabolism in the mouse. Am J Physiol 44:R667-R672, 1998,
8. Stangl GI. Conjugated linoleic acids exhibit a strong fat-to-lean partitioning effect, reduce serum VLDL lipids and redistribute tissue lipids in food-restricted rats. J Nutr 130:1140-1146, 2000.
9. Hayek MG, Han SN, Wu D, Watkins BA, Meydani M, Dorsey JL, Smith DE, Meydani SN. Dietary conjugated linoleic acid influences the immune response of young and old C57BL/6NCr1BR mice. J Nutr 129:32-38, 1999.
10. Yang M, Pariza MW, Cook ME. Dietary conjugated linoleic acid protects against end stage disease of systemic lupus erythematosus in the NZB/W F1 mouse. Immunopharmacol Immunotoxicol 22:433-449, 2000.
11. Sugano M, Tsujita A, Yamasaki M, Noguchi M, Yamada K. Conjugated linoleic acid modulates tissue levels of chemical mediators and immunoglobulins in rats. Lipids 33:521-527, 1998.
12. Cook ME, Miller CC, Park Y, Pariza M. Immune modulation by altered nutrient metabolism: nutritional control of immune-induced growth depression. Poult Sci 72:1301-1305, 1993.
13. Kelley VE, Ferretti A, Izui S, Strom TB. A fish oil diet rich in eicosapentaenoic acid reduces cyclooxygenase metabolites, and suppresses lupus in MRL-lpr mice. J Immunol 134:1914-1919, 1985.
14. Calder PC. Dietary fatty acids and the immune system. Nutr Rev 56:S70-S83, 1998.
15. Yaqoob P, Newsholme EA, Calder PC. The effect of dietary lipid manipulation on rat lymphocyte subsets and proliferation. Immunology 82:603-610, 1994.
16. Korver DR, Klasing KC. Dietary fish oil alters specific and inflammatory immune responses in chicks. J Nutr 127:2039-2046, 1997.
17. Flores EA, Bistrian BR, Pomposelli JJ, Dinarello CA, Blackburn GL, Istfan NW. Infusion of tumor necrosis factor/cachectin promotes muscle catabolism in the rat. A synergistic effect with interleukin 1. J Clin Invest 83:1614-1622, 1989.
18. Miller CC, Park Y, Pariza MW, Cook ME. Feeding conjugated linoleic acid to animals partially overcomes catabolic responses due to endotoxin injection. Biochem Biophys Res Commun 198:1107-1112, 1994.
19. Spellberg B, Edwards JE Jr. Type 1/Type 2 immunity in infectious diseases. Clin Infect Dis 32:76-102, 2001.
20. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-549, 1993.
21. + T cells to enhance priming for interferon-γ production and diminishes interleukin 4 inhibition of such priming. Proc Natl Acad Sci U S A 90:10188-10192, 1993.
22. Kopf M, Le Gros G, Bachmann M, Lamers MC, Bluethmann H, Kohler G. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362:245-248, 1993.
23. Betz M, Fox BS. Regulation and development of cytochrome c-specific IL-4-producing T cells. J Immunol 145:1046-1052, 1990.
24. Demeure CE, Wu CY, Shu U, Schneider PV, Heusser C, Yssel H, Delespesse G. In vitro maturation of human neonatal CD4 T lymphocytes. II. Cytokines present at priming modulate the development of lymphokine production. J Immunol 152:4775-4782, 1994.
25. Gajewski TF, Fitch FW. Anti-proliferative effect of IFN-γ in immune regulation. I. IFN-γ inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J Immunol 140:4245-4252, 1988.
26. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon-γ production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178:1041-1048, 1993.
27. Ohmori Y, Hamilton TA. IL-4-induced STAT6 suppresses IFN-γ-stimulated STAT1-dependent transcription in mouse macrophages. J Immunol 159:5474-5482, 1997.
28. Kuhn R, Rajewsky K, Muller W. Generation and analysis of interleukin-4-deficient mice. Science 254:707-710, 1991.
29. Punnonen J, Aversa G, Cocks BG, McKenzie AN, Menon S, Zurawski G, de Waal Malefyt R, de Vries JE. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci U S A 90:3730-3734, 1993.
30. Whigham LD, Cook EB, Stahl JL, Saban R, Bjorling DE, Pariza MW, Cook ME. CLA reduces antigen-induced histamine and PGE(2) release from sensitized guinea pig tracheae. Am J Physiol 280:R908-R912, 2001.
31. Hirai K, Yamaguchi M, Misaki Y, Takaishi T, Ohta K, Morita Y, Ito K, Miyamoto T. Enhancement of human basophil histamine release by interleukin 5. J Exp Med 172:1525-1528, 1990.
32. Roselaar SE, Daugherty A. Lipopolysaccharide decreases scavenger receptor mRNA in vivo. J Interferon Cytokine Res 17:573-579, 1997.
33. Coligan JE. Current Protocols in Immunology. New York: Greene Publishing Associates and Wiley-Interscience, 1991.
34. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142, 1991.
35. Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119:203-210, 1989.
36. Littell RC, Milliken GA, Stroup WW, Wolfinger RD. SAS System for Mixed Models. Cary, NC: SAS Institute, 1996.
37. Kinsella JE, Lokesh B, Broughton S, Whelan J. Dietary polyunsaturated fatty acids and eicosanoids: potential effects on the modulation of inflammatory and immune cells: an overview. Nutrition 6:24-44; discussion 59-62, 1990.
38. Renier G, Skamene E, DeSanctis J, Radzioch D. Dietary n-3 polyunsaturated fatty acids prevent the development of atherosclerotic lesions in mice. Modulation of macrophage secretory activities. Arterioscler Thromb 13:1515-1524, 1993.
39. Meydani SN, Endres S, Woods MM, Goldin BR, Soo C, Morrill-Labrode A, Dinarello CA, Gorbash SH. Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women. J Nutr 121:547-555, 1991.
40. Mascioli EA, Iwasa Y, Trimbo S, Leader L, Bistrian BR, Blackburn GL. Endotoxin challenge after menhaden oil diet: effects on survival of guinea pigs. Am J Clin Nutr 49:277-282, 1989.
41. Boutard V, Fouqueray B, Philippe C, Perez J, Baud L. Fish oil supplementation and essential fatty acid deficiency reduce nitric oxide synthesis by rat macrophages. Kidney Int 46:1280-1286, 1994.
42. Park Y. Regulation of Energy Metabolism and the Catabolic Effects of Immune Stimulation by Conjugated Linoleic Acid. PhD dissertation. Madison (WI): University of Wisconsin, 1996.
43. Park Y, Albright KJ, Storkson JM, Liu W, Cook ME, Pariza MW. Changes in body composition in mice during feeding and withdrawal of conjugated linoleic acid. Lipids 34:243-248, 1999.
44. Ip C, Chin SF, Scimeca JA, Pariza MW. Mammary cancer prevention by conjugated dienoic derivative oflinoleic acid. Cancer Res 51:6118-6124, 1991.
45. Chew BP, Wong TS, Shultz TD, Magnuson NS. Effects of conjugated dienoic derivatives of linoleic acid and β-carotene in modulating lymphocyte and macrophage function. Anticancer Res 17: 1099-1106, 1997.
46. Wong MW, Chew BP, Wong TS, Hosick HL, Boylston TD, Shultz TD. Effects of dietary conjugated linoleic acid on lymphocyte function and growth of mammary tumors in mice. Anticancer Res 17:987-993, 1997.
47. Snapper CM, Pecanha LM, Levine AD, Mond JJ. IgE class switching is critically dependent upon the nature of the B cell activator, in addition to the presence of IL-4. J Immunol 147:1163-1170, 1991.
48. Segal R, Bermas BL, Dayan M, Kalush F, Shearer GM, Mozes E. Kinetics of cytokine production in experimental systemic lupus erythematosus: involvement of T helper cell 1/T helper cell 2-type cytokines in disease. J Immunol 158:3009-3016, 1997.
49. Leslie CA, Gonnerman WA, Ullman MD, Hayes KC, Franzblau C, Cathcart ES. Dietary fish oil modulates macrophage fatty acids and decreases arthritis susceptibility in mice. J Exp Med 162:1336-1349, 1985.
50. Calder PC, Bond JA, Harvey DJ, Gordon S, Newsholme EA. Uptake and incorporation of saturated and unsaturated fatty acids into macrophage lipids and their effect upon macrophage adhesion and phagocytosis. Biochem J 269:807-814, 1990.
51. Fujikawa M, Yamashita N, Yamazaki K, Sugiyama E, Suzuki H, Hamazaki T. Eicosapentaenoic acid inhibits antigen-presenting cell function of murine splenocytes. Immunology 75:330-335, 1992.
52. Huang SC, Misfeldt ML, Fritsche KL. Dietary fat influences Ia antigen expression and immune cell populations in the murine peritoneum and spleen. J Nutr 122:1219-1231, 1992.
53. Calder PC. n-3 polyunsaturated fatty acids and cytokine production in health and disease. Ann Nutr Metab 41:203-234, 1997.
54. Pariza MW, Park Y, Cook ME. Mechanisms of action of conjugated linoleic acid: evidence and speculation. Exp Biol Med 223:8-13, 2000.
55. Chin SF, Storkson JM, Albright KJ, Cook ME, Pariza MW. Conjugated linoleic acid is a growth factor for rats as shown by enhanced weight gain and improved feed efficiency. J Nutr 124:2344-2349, 1994.
56. Park Y, Storkson JM, Albright KJ, Liu W, Pariza MW. Evidence that the trans-10,cis-12 isomer of conjugated linoleic acid induces body composition changes in mice. Lipids 34:235-241, 1999.
57. Roche HM, Noone E, Nugent A, Gibney MJ. Nutrient regulation of SRBEBPlc gene expression: CLA reduces plasma TAG concentrations by down-regulating hepatic SREBPlc in an isomer-specific effect of CLA on lipoprotein metabolism in man and gene expression in Ob/Ob mice. Ninety-second AOCS Annual Meeting and Expo. 2001 May 13-16; Minneapolis, Minnesota. Champaign (IL): AOCS Press, ppS58-S59.
58. Tisdale MJ. Biology of cachexia. J Natl Cancer Inst 89:1763-1773, 1997.
59. Swiergiel AH, Dunn AJ. The roles of IL-1, IL-6, and TNFα in the feeding responses to endotoxin and influenza virus infection in mice. Brain Behav Immun 13:252-265, 1999.
60. Costelli P, Carbo N, Tessitore L, Bagby GJ, Lopez-Soriano FJ, Argiles JM, Baccino FM. Tumor necrosis factor-α mediates changes in tissue protein turnover in a rat cancer cachexia model. J Clin Invest 92:2783-2789, 1993.
61. Remuzzi G, FitzGerald GA, Patrono C. Thromboxane synthesis and action within the kidney. Kidney Int 41:1483-1493, 1992.
62. Salvati P, Lamberti E, Ferrario R, Ferrario RG, Scampini G, Pugliese F, Barsotti P, Patrono C. Long-term thromboxane-synthase inhibition prolongs survival in murine lupus nephritis. Kidney Int 47:1168-1175, 1995.
63. Tomasoni S, Noris M, Zappella S, Gotti E, Casiraghi F, Bonazzola S, Benigni A, Remuzzi G. Upregulation of renal and systemic cyclooxygenase-2 in patients with active lupus nephritis. J Am Soc Nephrol 9:1202-1212, 1998.
64. Whigham LD. Inhibition of Lipid Mediators in Type 1 (Immediate) Hypersensitivity Immune Reaction by Conjugated Linoleic Acid (CLA). PhD dissertation. Madison (WI): University of Wisconsin, 2000.